Ery-Ped is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals). The primary component is Erythromycin Ethylsuccinate.
| Product ID | 24338-130_084f4439-0824-4419-9d4b-26916d0850b4 |
| NDC | 24338-130 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ery-Ped |
| Generic Name | Erythromycin Ethylsuccinate |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-06-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050207 |
| Labeler Name | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) |
| Substance Name | ERYTHROMYCIN ETHYLSUCCINATE |
| Active Ingredient Strength | 400 mg/5mL |
| Pharm Classes | Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2012-06-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050207 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-06-14 |
| Ingredient | Strength |
|---|---|
| ERYTHROMYCIN ETHYLSUCCINATE | 400 mg/5mL |
| SPL SET ID: | 04775721-ab87-4b66-808c-d67a21032385 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |